4.410CAD+3.52%Mkt Cap: 100.44M $P/E: —1d ago
HLS Therapeutics Inc., a specialty pharmaceutical company, acquires and commercializes pharmaceutical products for the treatment of psychiatric disorders and cardiovascular disease in Canada, the United States, and inter…
Industry Peers
Drug Manufacturers - Specialty & Genericvs Drug Manufacturers - Specialty & Generic
P/B
Avg
1M Perf
Avg
Indicators:|
Key Statistics
Company
Market Cap100.44M $
Enterprise Value123.46M $
Revenue (TTM)40.59M $
Gross Profit33.08M $
Net Income (TTM)-9.05M $
Revenue/Share1.293 USD
Last Price4.410 CAD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees85
CountryCA
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-103.44
PEG—
EV/EBITDA9.77
EV/Revenue3.04
P/S2.47
P/B1.66
EPS (TTM)-0.45
EPS (Forward)-0.04
52W Range
0.001076% of range5.765
52W High5.765 CAD
52W Low0.0010 CAD
Profitability
Gross Margin81.83%
Oper. Margin-17.22%
EBITDA Margin31.12%
Profit Margin-22.40%
ROE-20.16%
ROA-9.04%
Growth
Revenue Growth1.90%
Earnings Growth—
Cash Flow & Leverage
Operating CF12.48M $
CapEx (TTM)1.24M $
FCF Margin37.22%
FCF Yield15.04%
Net Debt23.02M $
Net Debt/EBITDA1.82
Balance Sheet
Debt/Equity0.81
Current Ratio1.00
Quick Ratio0.71
Book Value/Sh2.660 CAD
Cash/Share0.3940 CAD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 CAD
Div. Yield—
5Y Avg Yield1.73%
Payout Ratio0.00%
Ex-Div DateApr 27, 2023
Pay DateJun 15, 2023
Analyst Consensus
Rating—
Target (Mean)7.351 CAD
Upside (mean)+66.7%
Target Range4.637 CAD – 12.39 CAD
CAD4.637+66.7% to meanCAD12.39
# Analysts4
Ownership
Shares Out.31.27M
Float19.61M
Insiders0.53%
Institutions43.94%
Short Interest
Short Ratio0.3d
Short % Out.0.01%
Shares Short6.86K
Short (prev mo.)6.37K
Technical
SMA 504.527 (-2.6%)
SMA 2004.803 (-8.2%)
Beta0.85
S&P 52W Chg20.05%
Avg Vol (30d)20.59K
Avg Vol (10d)145.84K
Technical Indicators
RSI (14)50.6
MACD-0.0597
MACD Signal-0.0608
MACD Hist.+0.0011
BB Upper4.528 CAD
BB Middle4.362 CAD
BB Lower4.196 CAD
BB Width7.61%
ATR (14)0.2594 CAD
Vol Ratio (20d)24.82x